Multi-institution Analysis of Concurrent Chemoradiation Therapy With Cisplatin (CDDP) Versus Cetuximab (C225) in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which Agent?

被引：0
|
作者：
Riaz, N. [1 ]
Baschnagel, A. [2 ]
Adkins, D. [3 ]
Rao, S. [1 ]
Huang, J. [3 ]
Chen, P. [2 ]
Ley, J. [3 ]
Krauss, D. [2 ]
Thorstad, W. [3 ]
Lee, N. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Beaumont Hosp, Royal Oak, MI USA
[3] Washington Univ, St Louis, MO USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 32 条
  • [21] eVOLVE-HNSCC: A global phase 3 study of volrustomig as sequential therapy for unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) following definitive concurrent chemoradiotherapy (cCRT)
    Haddad, Robert I.
    Ruscica, Dario
    Visa, Alexandra
    Li, Xia
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Cisplatin Versus Cetuximab Combined With Radiation Therapy for Definitive Management of Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Matched Cohort Retrospective Analysis
    Smith, M. L.
    Arain, A. N.
    Herman, T. S.
    Bogardus, C. R., Jr.
    Matthiesen, C. L.
    Thompson, J. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E344 - E344
  • [23] Retrospective analysis of outcomes of cisplatin (CDDP) versus non cisplatin based treatment regimens for concurrent chemoradiotherapy (CCRT) in locally advanced squamous cell head and neck cancer (LA-SCCHN).
    Ashraf, Syed Muhammad Mushtaq
    Raufi, Ali Mehmood
    Barnett, William R.
    Williams, James Benjamin
    Skeel, Roland T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Pooled Analysis of Late Toxicity From 2 Randomized Phase 2 Trials of Induction Chemotherapy (IC) and Chemoradiation Therapy (CRT) for Locally Advanced Head and Neck Squamous Cell Cancer (LA-HNSCC)
    Melotek, J. M.
    Villaflor, V. M.
    Seiwert, T. Y.
    Kocherginsky, M.
    Karrison, T. G.
    Brisson, R. J.
    Blair, E. A.
    Stenson, K. M.
    Lingen, M.
    Cohen, E.
    Vokes, E. E.
    Haraf, D. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E351 - E352
  • [25] A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)
    Grover, Surbhi
    Mitra, Nandita
    Wan, Fei
    Lukens, John N.
    Sharma, Sonam
    Bauman, Jessica
    Masroor, Farzad
    Cohen, Roger B.
    Desai, Arati
    Algazy, Kenneth
    Alonso-Basanta, Michelle
    Ahn, Peter
    Teo, Boon-Keng Kevin
    Chalian, Ara A.
    Weinstein, Gregory S.
    O'Malley, Bert W., Jr.
    Lin, Alexander
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (05): : 522 - 527
  • [26] The role of cetuximab in induction chemotherapy: Comparison of APF-C (nab-paclitaxel, cisplatin, 5-FU + cetuximab) with APF, both followed by chemoradiation therapy (CRT), in patients with locally advanced head and neck squamous cell carcinoma (HNSCC).
    Adkins, Douglas
    Ley, Jessica C.
    Wildes, Tanya Marya
    Michel, Loren S.
    Rich, Jason
    Paniello, Randal
    Uppaluri, Ravi
    Thorstad, Wade L.
    Gay, Hiram Alberto
    Trinkaus, Kathryn
    Rachocki, Toni
    Nussenbaum, Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] JADE: A phase (ph) III study to evaluate dostarlimab vs placebo (PBO) as sequential therapy after chemoradiation (CRT) in patients (pts) with locally advanced unresected head and neck squamous cell carcinoma (LA-HNSCC)
    Machiels, J-P.
    Burtness, B.
    Harrington, K. J.
    Saba, N. F.
    Tahara, M.
    Crossman, T.
    Hua, L.
    Perera, A. D.
    Theti, D. S.
    Zografos, E.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2024, 35 : S655 - S655
  • [28] Correlation of CDKN2A genomic alterations with tumor response to palbociclib given before chemoradiation therapy (CRT) to patients with human papillomavirus (HPV)-negative, locally advanced head and neck squamous-cell carcinoma (LA-HNSCC): A single-arm, phase 2 trial.
    Oppelt, Peter John
    Ley, Jessica C.
    Paniello, Randal C.
    Puram, Sidharth
    Jackson, Ryan
    Pipkorn, Patrik
    Rich, Jason
    Gay, Hiram Alberto
    Liu, Jingxia
    Cohen, Jared
    Thorstad, Wade
    Adkins, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] A Phase 2-3 Study Comparing Concomitant Chemoradiation Therapy (CRT) Versus Cetuximab/RT (CET/RT) With or Without Induction Docetaxel/Cisplatin/5-Fluorouracil (TPF) in Locally-Advanced Head and Neck Squamous Cell Carcinoma (LASCCHN) - Efficacy Results of the GSTTC Italian Study (NCT01086826)
    Ghi, M.
    Paccagnella, A.
    Orecchia, R.
    Parisi, S.
    Bertoni, F.
    Minguzzi, N.
    Baggio, V.
    Polsinelli, M.
    Bunkheila, F.
    Palazzi, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S2 - S2
  • [30] Economic evaluation of the TAX 324 trial comparing docetaxel plus cisplatin and 5-fluorouracil (TPF) versus standard treatment with cisplatin and 5-fluorouracil (PF) as induction chemotherapy followed by concurrent chemoradiation therapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Parthan, A.
    Posner, M. R.
    Brammer, C.
    Beltran, P.
    Jansen, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
1234